Senior citizens and the burden of prescription drug outlaysWhat lessons for the medicare prescription drug benefit?

被引:2
|
作者
Panos Kanavos
Marin Gemmill
机构
[1] LSE Health and Social Care,London School of Economics and Political Science
关键词
Prescription Drug; Drug Expenditure; Private Health Insurance; Medical Expenditure Panel Survey; Federal Poverty Level;
D O I
10.2165/00148365-200403040-00005
中图分类号
学科分类号
摘要
This article uses data from a cohort of elderly and retired persons over the 1996–2001 period in the US to (i) determine the extent to which changes in socioeconomic or demographic characteristics, particularly age, income and education, impact the total amount that is spent on prescription drugs and (ii) to analyse the predictors of individual out-of-pocket (OOP) prescription drug outlays among the same cohort and determine whether age, race, sex, income, education, marital status and health status have an influence on these. The analysis considers the implications for elderly individuals who choose to participate in the new Medicare Part D drug benefit, labelled the Medicare Prescription Drug, Improvement, and Modernisation Act of 2003. The results highlight the necessity for the Medicare prescription drug benefit to carefully target the eldest among the elderly, who are most in need and are in danger of becoming trapped in the so-called Medicare ‘doughnut hole’, i.e. incur high prescription drug outlays, without adequate coverage. The study also finds evidence that women, those who are not married, middle income elderly and those in poor health, who purchase drugs more intensively, are at risk of incurring significant prescription OOP drug outlays.
引用
收藏
页码:217 / 227
页数:10
相关论文
共 50 条
  • [41] The new Medicare prescription-drug legislation
    Altman, DE
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (01): : 9 - 10
  • [42] Prescription-drug coverage for Medicare beneficiaries
    Iglehart, JK
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (10): : 923 - 925
  • [43] Prescription drug coverage among Medicare beneficiaries
    Regan, Joseph F.
    Petroski, Cara A.
    HEALTH CARE FINANCING REVIEW, 2007, 29 (01): : 119 - 125
  • [44] Assessing the new medicare prescription drug law
    Doherty, RB
    ANNALS OF INTERNAL MEDICINE, 2004, 141 (05) : 391 - 395
  • [45] PRESCRIPTION DRUG INSURANCE FOR ELDERLY UNDER MEDICARE
    STOLLEY, PD
    GODDARD, JL
    AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1971, 61 (03): : 574 - &
  • [46] Medicare prescription drug bill signed into law
    不详
    GERIATRIC NURSING, 2004, 25 (02) : 70 - 70
  • [47] A political history of medicare and prescription drug coverage
    Oliver, TR
    Lee, PR
    Lipton, HL
    MILBANK QUARTERLY, 2004, 82 (02): : 283 - +
  • [48] Prescription drug coverage and spending for Medicare beneficiaries
    Poisal, JA
    Murray, LA
    Chulis, GS
    Cooper, BS
    HEALTH CARE FINANCING REVIEW, 1999, 20 (03): : 15 - 27
  • [49] Medicare prescription drug plan moves forward
    Dawson, G
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2003, 95 (08) : 688 - 689
  • [50] Predictability of prescription drug expenditures for Medicare beneficiaries
    Wrobel, MV
    Doshi, J
    Stuart, BC
    Briesacher, B
    HEALTH CARE FINANCING REVIEW, 2003, 25 (02): : 37 - 46